Gabor Erdö

As a manager of technology transfers and oparations in DSP and aseptic filling of mAb and protein bulk for top pharmacetutical and research suppliers, when joining ITM - a startup in 2018 and today a market leader in radionuclide production with an expanding pipeline of radiopharmaceutical products I have witnessed various industry specific design aspects not known to most regulators. I have bundled a few of these for better orientation.